A novel role of the splenic volume in Crohn’s disease: evaluating the efficacy of infliximab

Background: A number of patients with Crohn’s disease (CD) suffer from loss of response to infliximab (IFX) therapy. Splenic volume is reported to be enlarged in patients with CD compared to normal individuals. The association between splenic volume and IFX efficacy in CD remains unclear. Methods: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xuan, Wang, Jia-Hui, Rao, Sheng-Xiang, Liu, Tao-Tao, Wu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470019/
https://www.ncbi.nlm.nih.gov/pubmed/37663264
http://dx.doi.org/10.3389/fphar.2023.1246657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470019/
https://www.ncbi.nlm.nih.gov/pubmed/37663264
http://dx.doi.org/10.3389/fphar.2023.1246657

Ejemplares similares